Fresh Tracks Therapeutics, Inc.
Biotechnology company · Boulder, Colorado, United States
Fresh Tracks Therapeutics, Inc. is a biotechnology company headquartered in Boulder, Colorado, United States. It has reported private securities offerings to the US SEC, most recently $10 sold in a notice filed in 2022.
Profile compiled from public records. Is this your company? Request a correction or update
Fresh Tracks Therapeutics at a glance
Typebiotechnology company
HeadquartersBoulder, Colorado, United States
SEC industryBiological Products, (No Diagnostic Substances)
SEC CIK819050
What does Fresh Tracks Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $10 sold (2022).
Frequently asked questions about Fresh Tracks Therapeutics
Where is Fresh Tracks Therapeutics headquartered?
Fresh Tracks Therapeutics, Inc. is headquartered in Boulder, Colorado, United States.
What does Fresh Tracks Therapeutics do?
Fresh Tracks Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Similar companies
- MBio Diagnostics, Inc.Boulder, Colorado, United States
- InDevR, Inc.Boulder, Colorado, United States
- Lazzaro Medical, Inc.Boulder, Colorado, United States
- EndoShape, Inc.Boulder, Colorado, United States
- AmideBio, LLCBoulder, Colorado, United States
- Orbit Genomics, Inc.Boulder, Colorado, United States
- Crestone, Inc.Boulder, Colorado, United States
- Enveda Therapeutics, Inc.Boulder, Colorado, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences